Samjin Pharm (005500) — Strategic Asset Allocation Index

Latest as of September 2018: 36.7%

Samjin Pharm (005500) has a Strategic Asset Allocation Index of 36.7% as of September 2018. Strategic assets (PP&E of ₩73.77 Billion plus long-term investments of ₩5.95 Billion) total ₩79.72 Billion, measured against net assets of ₩217.52 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

36.7%
Strategic Assets / Net Assets

Strategic Assets

₩79.72 Billion
PP&E + LT Investments

PP&E

₩73.77 Billion
KRW

Net Assets

₩217.52 Billion
KRW

Samjin Pharm Strategic Asset Allocation Index (2013–2017)

This chart shows how Samjin Pharm's Strategic Asset Allocation Index has evolved across 5 annual periods from 2013 to 2017. As of September 2018, the index stands at 36.7%, representing strategic assets of ₩79.72 Billion against net assets of ₩217.52 Billion KRW. Explore 005500 cash generation efficiency to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Samjin Pharm (2013–2017)

The table below presents the year-by-year Strategic Asset Allocation Index for Samjin Pharm from 2013 to 2017, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 005500 company net worth.

Year SAAI Strategic Assets (KRW) PP&E LT Investments Net Assets Change (pp)
2017 41.1% ₩79.54 Billion ₩74.87 Billion ₩4.67 Billion ₩193.47 Billion ▼ -4.3 pp
2016 45.4% ₩77.01 Billion ₩72.40 Billion ₩4.62 Billion ₩169.69 Billion ▼ -7.9 pp
2015 53.3% ₩78.89 Billion ₩71.15 Billion ₩7.74 Billion ₩148.06 Billion ▼ -8.0 pp
2014 61.3% ₩77.21 Billion ₩70.02 Billion ₩7.20 Billion ₩126.04 Billion ▼ -0.3 pp
2013 61.6% ₩69.59 Billion ₩62.88 Billion ₩6.71 Billion ₩112.98 Billion
pp = percentage points